Dec 2, 2024 · What is lapatinib? Lapatinib is used to treat advanced hormone-related breast cancer that has progressed or spread after treatment with other cancer medicines. Lapatinib is used for this condition only if your tumor tests positive for a protein called human epidermal growth factor receptor 2 (HER2). HER2 protein can speed the growth of cancer ...

Lapatinib , used in the form of lapatinib ditosylate (trade names Tykerb and Tyverb marketed by Novartis) is an orally active drug for breast cancer and other solid tumours. [3] It is a dual tyrosine kinase inhibitor which interrupts the HER2/neu and …

Sep 10, 2007 · Lapatinib is used in combination with capecitabine to treat advanced or metastatic (cancer that has already spread) HER2-receptor positive breast cancer in patients who have received other cancer treatments (eg, anthracycline, taxane, trastuzumab) that did not work well.

Lapatinib is an antineoplastic agent and tyrosine kinase inhibitor used for the treatment of advanced or metastatic HER-positive breast cancer in patients who received prior chemotherapeutic treatments.

What is this drug used for? It is used to treat breast cancer. What do I need to tell my doctor BEFORE I take this drug? If you are allergic to this drug; any part of this drug; or any other drugs, foods, or substances. Tell your doctor about the allergy and what signs you had.

Lapatinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells. How should this medicine be used? Lapatinib comes as a tablet to take by mouth.

May 1, 2024 · Tykerb (lapatinib) is a dual tyrosine kinase inhibitor and works by blocking both Epidermal Growth Factor Receptor (EGFR) and human epidermal growth factor receptor 2 (HER-2). This helps stop or slow the spread of breast cancer cells.

Dec 28, 2006 · Lapatinib, a tyrosine kinase inhibitor of human epidermal growth factor receptor type 2 (HER2, also referred to as HER2/neu) and epidermal growth factor receptor (EGFR), is active in combination...

Lapatinib ditosylate works by blocking the activity of HER2, a protein found in high levels on some cancer cells and causes them to grow. This may slow or stop the growth of cells that have a lot of HER2. Lapatinib ditosylate is a type of targeted therapy drug called a kinase inhibitor.

Medscape - Breast cancer dosing for Tykerb (lapatinib), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information....